:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Lydia Kuhnert, Philipp Stockmann, Peter Lönnecke, Mara Anna Wolniewicz, Evamarie Hey‐Hawkins, Walther Honscha
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	ChemMedChem
Online Access:	https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.202500708
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB 2 R) Ligands
by: Lea Ueberham, et al.
Published: (2025)

Advances in Diclofenac Derivatives: Exploring Carborane‐Substituted N‐Methyl and Nitrile Analogs for Anticancer Therapy
by: Christoph Selg, et al.
Published: (2025)

Exploring Raloxifene‐Based Metallodrugs: A Versatile Vector Combined with Platinum(II), Palladium(II) and Nickel(II) Dichlorides and Carborates against Triple‐Negative Breast Cancer
by: Aleksandr Kazimir, et al.
Published: (2024)

Front Cover: Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index (ChemMedChem 11/2025)
by: Lea Ueberham, et al.
Published: (2025)

Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index
by: Lea Ueberham, et al.
Published: (2025)

Decoding Urease Inhibition: A Comprehensive Review of Inhibitor Scaffolds
by: Nuno Martinho, et al.
Published: (2026)

Thiazole‐Based IL‐17 Inhibitors Discovered by Scaffold Morphing
by: Juraj Velcicky, et al.
Published: (2025)

CORRIGENDUM: Carboranes as Potent Phenyl Mimetics: A Comparative Study on the Reversal of ABCG2‐Mediated Drug Resistance by Carboranylquinazolines and Their Organic Isosteres
Published: (2024)

Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti‐SARS‐CoV‐2 Activity
by: Christian Gege, et al.
Published: (2024)

Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase Based on N , N′ ‐Diphenylurea
by: Artem Chayka, et al.
Published: (2025)

Front Cover: Structure‐Based Drug Design of Novel Heterocyclic Scaffolds as TgCDPK1 Inhibitors (ChemMedChem 18/2025)
by: Anoopjit Singh Kooner, et al.
Published: (2025)

Development of New Peptidomimetic NADPH Oxidase Inhibitors with Antithrombotic Properties
by: Elisabetta Scalia, et al.
Published: (2024)

Investigating the Ligand‐Binding Properties of N‐arylbenzimidazoles as Novel Elastase Inhibitors
by: Giovanna Pitasi, et al.
Published: (2025)

Development of Keap1‐Nrf2 Protein–Protein Interaction Inhibitor Activating Intracellular Nrf2 Based on the Naphthalene‐2‐acetamide Scaffold, and its Anti‐Inflammatory Effects
by: Daisuke Yasuda, et al.
Published: (2025)

Towards Improved Peptidic α‐Ketoamide Inhibitors of the Plasmodial Subtilisin‐Like SUB1: Exploration of N‐Terminal Extensions and Cyclic Constraints
by: Anna K. Puszko, et al.
Published: (2025)

Design, Synthesis, and Evaluation of New Polyhydroxylated B is ‐Chalcones as Potential COX‐2 Selective Inhibitors
by: Rui Pereira, et al.
Published: (2026)

Exploration of Antiplasmodium Chemical Space Identifies New Inhibitors of β ‐Hematin Formation from Areas of Enrichment
by: Jessica L. Thibaud, et al.
Published: (2026)

Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors
by: Ismail Koyuncu, et al.
Published: (2024)

Progress In the Chemistry and Pharmacology of Isoindolin‐1‐One Scaffolds
by: Kunal Madaan, et al.
Published: (2025)

Developing Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase
by: Artem Chayka, et al.
Published: (2024)

Discovery of Galactopyranose‐1‐carboxamides as a New Class of Small, Novel, Potent, Selective, and Orally Active Galectin‐3 Inhibitors
by: Cornelia Zumbrunn, et al.
Published: (2025)

Targeting Plasmodium falciparum Single‐Stranded DNA‐Binding Protein: Discovery of New Scaffold Compounds Effective against Drug‐Sensitive and Artemisinin‐Resistant Strains
by: Biswajit Naik, et al.
Published: (2025)

Benzimidazole as a Versatile Scaffold for Developing Neurotherapeutics Against Neurodegenerative Diseases
by: Nivedita Barnwal, et al.
Published: (2026)

Targeting N‐Methyl‐lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery
by: Ilaria Cursaro, et al.
Published: (2024)

Structural Basis for Inhibition of the SARS‐CoV‐2 nsp16 by Substrate‐Based Dual Site Inhibitors
by: Gints Kalnins, et al.
Published: (2024)

APH Inhibitors that Reverse Aminoglycoside Resistance in Enterococcus casseliflavus
by: Elise Kaplan, et al.
Published: (2025)

The Role of Protein Disulfide Isomerase Inhibitors in Cancer Therapy
by: Qiuying Nie, et al.
Published: (2024)

Challenges for the Discovery of Non‐Covalent WRN Helicase Inhibitors
by: Alisa Heuser, et al.
Published: (2024)

CORRIGENDUM: α‐Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML
Published: (2025)

Phenotypic‐Based Discovery and Exploration of a Resorufin Scaffold with Activity against Mycobacterium tuberculosis
by: Eric Tran, et al.
Published: (2024)

Small‐Molecule KRAS Inhibitors by Tyrosine Covalent Bond Formation
by: Alexander D. Landgraf, et al.
Published: (2025)

Binding‐Site Switch for Protein Kinase CK2 Inhibitors
by: Dylan Grenier, et al.
Published: (2025)

Gram‐Scale Synthesis of an Arylsulfonamide‐Type Alkaline Phosphatase Inhibitor
by: Zsolt Rapi, et al.
Published: (2026)

Biaryl Phosphate‐Based Inhibitors of the Transcription Factor STAT4
by: Nadiya Brovchenko, et al.
Published: (2025)

Repurposing of Inhibitors of Plasmodial Aspartate Transcarbamoylase Toward Trypanosoma Cruzi
by: Siyao Chen, et al.
Published: (2026)

Balinatunfib: A Clinical Oral Small Molecule TNFα Inhibitor
by: Alexander Dömling, et al.
Published: (2025)

2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors
by: Zheng Ma, et al.
Published: (2025)

Structure‐Atropisomer Stability Relationship in Selective MCL‐1 Inhibitors
by: Szabolcs Sipos, et al.
Published: (2025)

From Deep Learning to the Discovery of Promising VEGFR‐2 Inhibitors
by: Mehmet Ali Yucel, et al.
Published: (2024)

Flavonoid‐Quinoxaline Hybrid Compounds as Cathepsin Inhibitors Against Fascioliasis
by: Florencia Ferraro, et al.
Published: (2024)